Isracann Biosciences Stock Forecast for 2023 - 2025 - 2030
Updated on 05/06/2024
Isracann Biosciences Fair Value Forecast for 2023 - 2025 - 2030
Isracann Biosciences's Price has grown in the last year, jumping from C$0.00 to C$0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach C$0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| T Stock Forecast | TELUS | Outperform |
18
|
C$22.39 | Buy/Sell | C$28.53 | 16.12% |
| MARA Stock Forecast | Marathon Digital Holdings | Outperform |
11
|
$17.52 | Buy/Sell | $12.88 | 54.11% |
| CLSK Stock Forecast | CleanSpark | Buy |
7
|
$16.15 | Buy/Sell | $11.87 | 48.61% |
| RIOT Stock Forecast | Riot Platforms | Buy |
9
|
$10.42 | Buy/Sell | $16.15 | 67.95% |
| SGD Stock Forecast | Snowline Gold | Buy |
4
|
C$5.69 | Buy/Sell | C$10.38 | 62.57% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BITF Stock Forecast | Bitfarms | Buy |
11
|
C$2.51 | Buy/Sell | C$6.62 | 88.05% |
| HIVE Stock Forecast | HIVE Digital Technologies | Outperform |
12
|
C$3.34 | Buy/Sell | C$20.00 | -100.00% |
| ARB Stock Forecast | Argo Blockchain | Hold |
11
|
£0.11 | Buy/Sell | £0.10 | 9.09% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DMGI Stock Forecast | DMG Blockchain Solutions | Outperform |
-18
|
C$0.49 | Buy/Sell | C$1.00 | 104.08% |
| DGHI Stock Forecast | Digihost Technology | Outperform |
-14
|
C$2.06 | Buy/Sell | C$10.50 | -100.00% |
| TGO Stock Forecast | TeraGo | Hold |
0
|
C$1.96 | Buy/Sell | C$2.60 | 32.65% |
Isracann Biosciences EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Isracann Biosciences's EBITDA has fallen from C$-11.18M to C$-2.39M – a 78.62% decrease. In the next year, analysts expect EBITDA to reach C$-5.05M – an increase of 111.30%. For the next eight years, the forecast is for EBITDA to grow by 183.52%.
Isracann Biosciences EBIT Forecast for 2023 - 2025 - 2030
Isracann Biosciences's EBIT has decreased In the last two years, from C$-11.22M to C$-2.43M – a 78.34% drop. The next year looks promising for Isracann Biosciences, with analysts predicting EBIT of C$-5.10M – an increase of 109.83%. Over the next eight years, experts anticipate that Isracann Biosciences's EBIT will grow at a rate of 179.97%.
Isracann Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
Isracann Biosciences's EPS has grown in the last year, jumping from C$0.00 to C$0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach C$0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
.jpg)